share_log

聖諾醫藥-B:自願性公告 - Sirnaomics用於治療原位鱗狀細胞癌的STP705的進一步研發獲得FDA的具體指導建議

SIRNAOMICS-B: VOLUNTARY ANNOUNCEMENT - SIRNAOMICS RECEIVED FDA SPECIFIC GUIDANCE FOR FURTHER DEVELOPMENT OF STP705 FOR TREATMENT OF SQUAMOUS CELL CARCINOMA IN SITU

Hong Kong Stock Exchange ·  Apr 16 10:28
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more